Strs Ohio Atea Pharmaceuticals, Inc. Transaction History

Strs Ohio

$23.2 Billion
Q1 2025

A detailed history of Strs Ohio transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Strs Ohio holds 105,500 shares of AVIR stock, worth $394,570. This represents 0.0% of its overall portfolio holdings.

Number of Shares

105,500

Previous 105,500 -0.0%

Holding current value

$394,570

Previous $353,000 10.76%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	BUY	$3.31 - $4.04 $35,748 - $43,632	10,800 Added 11.4%	105,500 $349,000
Q1 2024 May 13, 2024	SELL	$3.09 - $4.56 $18,540 - $27,359	-6,000 Reduced 5.96%	94,700 $382,000
Q2 2023 Jul 31, 2023	BUY	$3.21 - $5.06 $17,655 - $27,829	5,500 Added 5.78%	100,700 $376,000
Q1 2023 Aug 02, 2023	SELL	$3.0 - $4.97 $16,500 - $27,335	-5,500 Reduced 5.46%	95,200 $318,000
Q1 2023 Apr 27, 2023	SELL	$3.0 - $4.97 $98,100 - $162,519	-32,700 Reduced 25.57%	95,200 $318,000
Q4 2022 Jan 26, 2023	BUY	$4.35 - $6.17 $160,080 - $227,056	36,800 Added 40.4%	127,900 $615,000
Q3 2022 Oct 27, 2022	SELL	$5.49 - $8.79 $21,411 - $34,281	-3,900 Reduced 4.11%	91,100 $518,000
Q2 2022 Jul 25, 2022	SELL	$5.33 - $8.18 $152,971 - $234,766	-28,700 Reduced 23.2%	95,000 $674,000
Q1 2022 Apr 21, 2022	BUY	$5.5 - $9.19 $141,350 - $236,183	25,700 Added 26.22%	123,700 $893,000
Q4 2021 Jan 24, 2022	BUY	$7.67 - $44.59 $461,734 - $2.68 Million	60,200 Added 159.26%	98,000 $876,000
Q3 2021 Oct 22, 2021	BUY	$21.33 - $35.06 $14,930 - $24,542	700 Added 1.89%	37,800 $1.33 Million
Q2 2021 Jul 26, 2021	BUY	$19.22 - $59.08 $555,458 - $1.71 Million	28,900 Added 352.44%	37,100 $796,000
Q1 2021 Apr 23, 2021	BUY	$41.42 - $88.44 $194,674 - $415,668	4,700 Added 134.29%	8,200 $506,000
Q4 2020 Jan 25, 2021	BUY	$26.36 - $41.78 $92,260 - $146,230	3,500 New	3,500 $146,000

Others Institutions Holding AVIR

# of Institutions

109

Shares Held

48.3M

Call Options Held

3.4K

Put Options Held

14.5K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $311M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account